Bioceltix S.A. announced a private placement of 140,536 common shares at the price of PLN 30 per share for gross proceeds of PLN 4.21608 million on July 18, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
64 PLN | -0.47% | -1.39% | -28.89% |
May. 29 | Bioceltix S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Bioceltix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-28.89% | 67.09M | |
-12.91% | 78.43B | |
+22.15% | 8.99B | |
+25.50% | 3.72B | |
-2.92% | 3.19B | |
+11.32% | 1.67B | |
-2.44% | 1.3B | |
-25.16% | 1.24B | |
-27.23% | 1.22B | |
-18.50% | 1.07B |
- Stock Market
- Equities
- BCX Stock
- News Bioceltix S.A.
- Bioceltix S.A. announced that it expects to receive PLN 4.21608 million in funding